Gabapentin muscle spasms
Pro Research Analysisby 
Searched over 200M research papers
Gabapentin for Muscle Spasms: Efficacy and Applications
Gabapentin and Multiple Sclerosis-Related Muscle Spasms
Efficacy in Treating Spasticity and Painful Muscle Spasms
Gabapentin has been shown to be effective in treating spasticity and painful muscle spasms in patients with multiple sclerosis (MS). In a double-blind, placebo-controlled crossover study, patients receiving 400 mg of gabapentin three times daily experienced significant improvements in spasticity and muscle cramps, as measured by the Ashworth Scale, Visual Faces Scale, and Kurtzke Disability Scale . Another study corroborated these findings, demonstrating that gabapentin significantly reduced spasticity severity and interference with daily functions, without impairing concentration or increasing fatigue .
Quantitative Assessments and Higher Doses
Further research using surface electromyography (EMG) techniques indicated that gabapentin at doses of 400 mg three times daily may control some features of spasticity in individuals with spinal cord injury (SCI). However, higher doses (up to 3600 mg/day) were found to provide greater control of spasticity, suggesting that dose adjustments could enhance therapeutic outcomes .
Gabapentin for Spasticity in Upper Motor Neuron Syndrome
Clinical Trials and Safety
A randomized, double-blind, placebo-controlled trial involving patients with upper motor neuron syndrome demonstrated that gabapentin, at doses between 2700 and 3600 mg/day, significantly improved spasticity as measured by the Ashworth Scale. The treatment was well-tolerated, with fewer adverse events compared to placebo, indicating both efficacy and safety in this patient population .
Gabapentin in Spinal Cord Injury-Related Spasticity
Clinical Improvements and Patient Ratings
In a study involving patients with spinal cord injury, gabapentin administration resulted in an 11% reduction in spasticity as measured by the Ashworth Scale and a 20% reduction in patient-reported spasticity severity on the Likert Scale. These findings suggest that gabapentin can be a useful management option for spasticity in spinal cord injury patients .
Gabapentin for Isaacs' Syndrome and Hemifacial Spasm
Isaacs' Syndrome
Gabapentin has also shown efficacy in treating Isaacs' syndrome, a condition characterized by continuous muscle spasms and stiffness. A case study reported dramatic improvement in muscle spasms and reduced motor-unit activity following gabapentin treatment, highlighting its potential as an effective therapy for this rare condition .
Hemifacial Spasm
Gabapentin has been effective in reducing involuntary facial muscle contractions in patients with hemifacial spasm. Studies have shown significant reductions in spasm frequency and severity with gabapentin doses ranging from 900 to 1600 mg daily, providing a favorable therapeutic effect with minimal side effects Bandini1999Daniele2001.
Gabapentin and Muscle Pain
Limited Efficacy in Muscle Pain
While gabapentin is effective in reducing cutaneous pain and central sensitization, it appears to have limited efficacy in treating muscle pain. A study involving healthy volunteers found that gabapentin did not significantly affect muscle pain induced by hypertonic saline infusion, suggesting that its analgesic effects may be more pronounced in neuropathic pain rather than muscle pain .
Conclusion
Gabapentin has demonstrated significant efficacy in treating spasticity and muscle spasms associated with multiple sclerosis, spinal cord injury, upper motor neuron syndrome, Isaacs' syndrome, and hemifacial spasm. However, its effectiveness in treating muscle pain remains limited. These findings underscore the importance of considering gabapentin as a therapeutic option for specific types of muscle spasms and spasticity, while recognizing its limitations in addressing muscle pain.
Sources and full results
Most relevant research papers on this topic